Position in MRNA
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$420
New position
Shares Held
6
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#752
of 772 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 20261015 Capital Partners, LLC holds $35,719 across 10 Biotechnology names. MRNA ranks #6 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
337 | $18,336 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17 | $10,600 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7 | $3,477 | |
| 4 | INCY |
Incyte Corp
|
9 | $1,020 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3 | $903 | |
| 6 | MRNA |
Moderna, Inc.
This page
|
6 | $420 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2 | $374 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
9 | $318 |
All Filings in MRNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $420 | 6 | Shares | Sole | 2026-07-21 | |
| No filing history on record for this holder in this stock. | ||||||